Related Experiment Video
Updated: Sep 30, 2025
05:46
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
5.3K
Novel Nitrile Peptidomimetics for Treating COVID-19
1Experimental Drug Development Centre, 10 Biopolis Road, Chromos #08-01, Singapore 138670.
ACS Medicinal Chemistry Letters
|March 16, 2022
Summary
This review examines Nirmatrelvir, an oral COVID-19 antiviral, and its structure-activity relationship. It focuses on key inhibitors detailed in patent WO 2021/250648 A1 for treating SARS-CoV-2 infections.
Area of Science:
- Virology
- Medicinal Chemistry
- Pharmaceutical Sciences
Background:
- Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) causes COVID-19, a pandemic leading to millions of deaths.
- The U.S. FDA authorized Nirmatrelvir, an oral main protease inhibitor, for mild-to-moderate COVID-19 treatment.
- Antiviral drug development is crucial for managing infectious diseases like COVID-19.
Discussion:
- This patent review analyzes the structure-activity relationship (SAR) of SARS-CoV-2 main protease inhibitors.
- Patent WO 2021/250648 A1 describes key compounds targeting viral replication.
- Understanding SAR is vital for optimizing antiviral efficacy and drug design.
Key Insights:
- The patent details specific chemical structures and their inhibitory activity against SARS-CoV-2.
- Nirmatrelvir's mechanism involves inhibiting the viral main protease essential for viral replication.
- Structure-activity relationship data informs the development of next-generation COVID-19 therapeutics.
Outlook:
- Further research into these inhibitors could lead to improved oral antiviral treatments for COVID-19.
- Optimization of lead compounds may enhance potency and pharmacokinetic profiles.
- This patent review contributes to the ongoing effort to combat the COVID-19 pandemic through medicinal chemistry.
Related Concept Videos
01:12Preparation of Nitriles
2.2K
One of the common methods to prepare nitriles is the dehydration of amides. This method requires strong dehydrating agents like phosphorous pentoxide or boiling acetic anhydride for converting amides to nitriles. Another reagent namely, thionyl chloride also accomplishes the dehydration of amides, where amide acts as a nucleophile. The first step of the mechanism involves the nucleophilic attack by the amide on the thionyl chloride to form an intermediate. In the next step, the electron pairs...
2.2K
01:38Preparation of Amines: Reductive Amination of Aldehydes and Ketones
3.2K
Carbonyl compounds and primary amines undergo reductive amination first to produce imines, followed by secondary amines in the same reaction mixture, using selective reducing agents like sodium cyanoborohydride or sodium triacetoxyborohydride. Reductive amination produces different degrees of substitution of amines depending on the starting amine substrate.
3.2K
01:29Preparation of Amines: Reduction of Oximes and Nitro Compounds
4.1K
Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
4.1K